55436-41-4

Usage

Chemical class

Piperazine derivative It is a compound derived from the base structure of piperazine.

Structural features

Piperazine core with two benzo[1,3]dioxole groups attached The presence of these groups contributes to its potential biological activity.

Molecular weight

Approximately 360 g/mol Indicates the mass of one mole of the compound.

Appearance

Solid Describes the physical state of the compound at room temperature.

Solubility

Soluble in organic solvents It can dissolve in solvents like methanol, ethanol, or dimethyl sulfoxide (DMSO).

Potential applications

Medicinal chemistry and drug development Due to its structural features and the presence of biologically active moieties, it may have uses in the development of new pharmaceuticals.

Biological activity

Presence of piperazine and benzo[1,3]dioxole moieties These moieties are known to have biological activity, which may contribute to the compound's potential uses in medicine.

Further research

Pharmacological properties and potential uses Additional studies are needed to fully understand the compound's properties and how it can be applied in the medical field.

Safety and toxicity

Unknown The safety and toxicity profiles of 1,4-bis(benzo[1,3]dioxol-5-ylmethyl)piperazine have not been extensively studied and are not well-established. Caution should be exercised when handling and using 1,4-bis(benzo[1,3]dioxol-5-ylmethyl)piperazine.

InChI:InChI=1/C20H22N2O4/c1-3-17-19(25-13-23-17)9-15(1)11-21-5-7-22(8-6-21)12-16-2-4-18-20(10-16)26-14-24-18/h1-4,9-10H,5-8,11-14H2

Upstream product

• 110-85-0 piperazine 
• 20850-43-5 5-(chloromethyl)-1,3-benzodioxole 
• 57-09-0 cetyltrimethylammonim bromide 
• 142-63-2 piperazine hexahydrate 

Downstream Products

• 34161-23-4 1-(3',4'-methylenedioxybenzyl)-4-(4-chlorophenoxyacetyl)-piperazine hydrochloride 

Relevant academic research and scientific papers

PLANT GROWTH-PROMOTION AGENT AND METHOD FOR PROMOTING PLANT GROWTH

The present invention concerns: a plant growth-promoting agent comprising a compound represented by Formula (I) or a salt thereof: wherein Ar1 represents a substituted or unsubstituted phenyl group, NZ represents a nitrogen-containing heterocyclic ring group or an acyclic nitrogen-containing group having a partial structure of the nitrogen-containing heterocyclic ring group, n is 0, 1, or 2, R1 and R2 each represent a hydrogen atom, a substituted or unsubstituted C1-3-alkyl group, a cyano group, or a carboxyl group, R1 and R2 may together form an oxo group, and when n is 2, R1 or R2 may be the same or different; and a method for promoting plant growth using the plant growth-promoting agent.

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE

Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially A? amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinophathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

Process for preparing p-chlorophenoxy-acetyl-piperonylpiperazine hydrochloride

The subject compound, otherwise known as Fipexidum hydrochloride, is obtained by reacting the chloride of p-chlorophenoxyacetic acid with 1,4-bis-piperonylpiperazine, preferably in benzene solution under reflux conditions in the presence of a base such as sodium bicarbonate. The advantages of the process are low cost and high overall conversion due to easy recovery and recycle of relevant substances.

Non anticholinergic gastric acid secretion inhibitors. New piperazine and related derivatives

Some of the new piperazine derived compounds exhibited interesting gastric antisecretory properties without anticholinergic action. 1 Piperonyl 4 (3,7,11 trimethyl 2,6,10 dodecatrienyl) piperazine was the most active as an antisecretory agent in rat. Some analogous compounds, with the piperazine ring replaced by other heterocyclic or acyclic amines, were also prepared. Structure activity relationships are discussed.